openPR Logo
Press release

Emerging Trends Influencing The Growth Of The Nuclear Medicine Diagnostics Market: Advancements In Nuclear Medicine Diagnostics Define The Future Of Patient-Centric Solutions

05-14-2025 11:55 AM CET | Health & Medicine

Press release from: The Business Research Company

Nuclear Medicine Diagnostics Market Size

Nuclear Medicine Diagnostics Market Size

The Nuclear Medicine Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Nuclear Medicine Diagnostics Market?
In recent times, there has been a swift expansion in the dimension of the nuclear medicine diagnostics market. The market value is projected to rise from $7.16 billion in 2024 to a staggering $7.94 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.0%. Several factors are behind this growth in the preceding period, such as advancements in medical imaging technology, a rise in chronic disease cases, aging demographics, the usage of clinical applications in the field of oncology, along with diagnostic accuracy and precision.

In the coming years, the nuclear medicine diagnostics market is set to experience rapid expansion, growing to a value of $12.56 billion in 2029, at a compound annual growth rate (CAGR) of 12.1%. The predicted growth during this period is boosted by the widening scope for use in neurology, integration with other image-capturing methods, precision medicine techniques, increased need for theranostics, and worldwide initiatives in eliminating diseases. Some key trends anticipated to shape the future market include the move towards smaller, more decentralized radiopharmacy, the use of nuclear medicine in neurology, radiomics and the analysis of quantitative imaging, research and development partnerships, and a focus on radiation safety and dosimetry.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9415

What Are the Different Nuclear Medicine Diagnostics Market Segments?
The nuclear medicine diagnostics market covered in this report is segmented -

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Institutes

Subsegments:
1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals
2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp

What Are the Primary Drivers Shaping the Nuclear Medicine Diagnostics Market?
The escalating need for nuclear medicine diagnostics is anticipated to spur the expansion of the nuclear medicine diagnostics market in the future. Nuclear medicine employs radioactive substances within the body to identify diseases or specifically aim at and eliminate unhealthy or impaired organs and tissue for therapeutic purposes. The diagnostic applications of nuclear medicine are predominantly in radiation and other lethal treatments. The requirement for nuclear medicine diagnostics is on the rise owing to advantages like precise outcomes and improved treatment decision-making process. For example, a report published by the United Kingdom's World Nuclear Association in April 2022 reveals that the yearly number of nuclear medicine treatments surpasses 40 million and the demand for radioisotopes is growing up to 5% each year. Furthermore, in over 10,000 hospitals globally, radioisotopes are involved in 90% of the medical procedures. Consequently, the growing need for nuclear medicine diagnostics is predicted to stimulate the progression of the nuclear medicine diagnostics market.

Which Companies Are Leading in the Nuclear Medicine Diagnostics Market?
Major companies operating in the nuclear medicine diagnostics market include Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Global Medical Solutions LLC, Theragnostics Ltd., Eczacibasi-Monrol Nuclear Products Co.

What Trends Are Expected to Dominate the Nuclear Medicine Diagnostics Market in the Next 5 Years?
Leading corporations in the nuclear medicine diagnostics market are endeavoring to bring forth innovative solutions such as sophisticated medical technologies, aiming to secure an advantageous position. These state-of-the-art medical technologies aim to enhance patient results, raise healthcare quality, and foster improved well-being. For example, in August 2023, Gleneagles Hospital, a Malaysian-based firm providing medical and healthcare facilities, initiated its Nuclear Medicine Unit. This unit, a highly specialized facility within the hospital or medical center, is equipped with the most recent technology and staffed by highly trained experts. The purpose of this facility is to allow early detection, diagnose, and treat diseases employing nuclear medicine imaging methods.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

What Are the Top Revenue-Generating Geographies in the Nuclear Medicine Diagnostics Market?
North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Nuclear Medicine Diagnostics Market?
2. What is the CAGR expected in the Nuclear Medicine Diagnostics Market?
3. What Are the Key Innovations Transforming the Nuclear Medicine Diagnostics Industry?
4. Which Region Is Leading the Nuclear Medicine Diagnostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Emerging Trends Influencing The Growth Of The Nuclear Medicine Diagnostics Market: Advancements In Nuclear Medicine Diagnostics Define The Future Of Patient-Centric Solutions here

News-ID: 4015371 • Views:

More Releases from The Business Research Company

Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by 2029
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025? Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billion by 2029
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Rheology Modifiers Industry? There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analysis Report
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025? In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growth at 7.1% CAGR Forecast
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Pharmaceutical Intermediates Industry? There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound

All 5 Releases


More Releases for Nuclear

Nuclear Energy Market is Going to Boom : GE Hitachi Nuclear Energy, China Nation …
HTF MI introduces new research on Nuclear Energy covering the micro level of analysis by competitors and key business segments (2023-2029). The Nuclear Energy explores a comprehensive study of various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing. Some of the major key players profiled
Nuclear Technology Market Is Booming Worldwide | Areva, Foro Nuclear, Emirates N …
Advance Market Analytics published a new research publication on "Nuclear Technology Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Nuclear Technology market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample Copy of
Nuclear Reactor Market - Crucial business trends 2025 | FirstEnergy Nuclear Gene …
Global Nuclear Reactor Market: Snapshot The global market for nuclear reactors is likely to take significant strides, thanks to the growing need for emission-free energy generation systems over the globe. The emergence of new nuclear power plants has also been responsible for the progress of the worldwide nuclear reactor market. In June 2017, for example, Russia announced that it was in advanced stages of constructing the world’s first ever ‘floating’
Nuclear Reactor Market - Promising growth opportunities 2025 | FirstEnergy Nucle …
Global Nuclear Reactor Market: Snapshot The global market for nuclear reactors is likely to take significant strides, thanks to the growing need for emission-free energy generation systems over the globe. The emergence of new nuclear power plants has also been responsible for the progress of the worldwide nuclear reactor market. In June 2017, for example, Russia announced that it was in advanced stages of constructing the world’s first ever ‘floating’
Nuclear Energy Industry Analysis of Nuclear Fuels Market 2017-2021
Nuclear fuel is a substance used to initiate and sustain a nuclear fission reaction in nuclear power stations to generate heat. This heat powers turbine to produce usable electrical energy. A nuclear reactor is a structure in which fissile material undergoes a controlled, self-sustaining nuclear reaction with simultaneous release of energy, which can be used to generate electricity. . . – Get Sample Report_https://www.researchmoz.us/enquiry.php?type=S&repid=1069449 ' ' Global nuclear fuels market to grow
UAE Nuclear Power Sector UAE Nuclear Power Sales Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. UAE Power Sector Scenario 1.1 Existing Power Generation Outlook 1.2 Current & Projected Power Demand 2. Why UAE Energy Policy beyond Oil & Gas? 3. UAE Nuclear Power Sector Overview 3.1 UAE Entering into Nuclear Power Sector 3.2 Nuclear Policy Overview 4. UAE Nuclear Power Sector Dynamics 4.1 Favorable Parameters 4.2 Nuclear Power Sector